Placebo / Saline

DRUG2 trials

Sponsors

Dr. Brian Hallahan, Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Conditions

ALS (Amyotrophic Lateral Sclerosis)Bipolar Disorder Depression

Phase 2

Scopolamine in Bipolar Depression

CompletedNCT04211961

Dr. Brian HallahanBipolar Disorder Depression

Start: 2021-03-23End: 2024-02-22Updated: 2025-04-29

Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis

Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaALS (Amyotrophic Lateral Sclerosis)

Start: 2021-05-01End: 2023-09-01Target: 100Updated: 2021-04-19

Related Papers

Antidepressant efficacy and safety of scopolamine in individuals with bipolar disorder (SCOPE-BD): A randomized double-blind placebo-controlled trial.

2025-12-16

Efficacy and safety of scopolamine compared to placebo in individuals with bipolar disorder who are experiencing a depressive episode (SCOPE-BD): study protocol for a randomised double-blind placebo-controlled trial

Trials2022-04-237 citations